The global mammography devices market size was estimated to be USD 1.54 billion in 2023 and is expected to reach USD 4.50 billion by 2034 with a CAGR of 10.21% during the forecast period 2024-2034. Increasing breast cancer incidence, increasing breast cancer incidence, government initiatives and screening programs, increasing healthcare expenditure, awareness and education campaigns, rising patient preference for non-invasive procedures, and improvements in reimbursement policies will drive market growth.
Breast cancer is the most frequent cancer in women across the world, and its prevalence is increasing. This is due to a combination of variables such as aging populations, lifestyle changes, and improved screening technologies. Breast cancer identification is critical for improving treatment results and lowering death rates. Mammography is the most efficient early detection method for breast cancer, and public awareness of its relevance is expanding. For instance, Hologic, Inc. received FDA authorization for their new 3D GeniusTM Dream Edition mammography equipment with increased picture quality and quicker scan durations in December 2023.
By product, the digital mammography systems segment accounted for the highest revenue-grossing segment in the global mammography devices market in 2023 owing to the increasing adoption of advanced imaging technologies, enhanced diagnostic accuracy, and the growing trend towards digitalization in medical imaging. For instance, in September 2023, the company received CE Mark clearance for their Biograph mPower PET/CT system, which provides enhanced imaging for breast cancer staging and therapy planning. Additionally, the 3D mammography systems segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing acknowledgment of its better diagnostic capabilities, particularly in identifying breast cancer in patients with dense breast tissue.
By technology, the digital mammography segment accounted for the highest revenue-grossing segment in the global mammography devices market in 2023 owing to the increasing demand for advanced imaging technologies, a shift toward digitalization in healthcare, and the numerous advantages offered by digital mammography over traditional analog systems. For instance, in December 2023, GE Healthcare demonstrated their new Senographe Pristina 3D mammography system with AI-powered lesion detection at the RSNA annual meeting. Additionally, the 3D mammography segment is predicted to grow at the fastest CAGR during the forecast period owing to the heightened demand for improved breast cancer detection accuracy, particularly in individuals with dense breast tissue.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global mammography devices market in 2023 owing to the pivotal role hospitals play as primary healthcare centers, where a significant volume of mammography screenings and diagnostic procedures are conducted. For instance, Fujifilm Holdings Corporation collaborated with AI developer Subtle Medical in August 2023 to create AI-powered breast cancer screening capabilities for its mammography equipment. Additionally, the diagnostic imaging centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend toward outpatient services, the rising demand for specialized diagnostic procedures, and the convenience offered by dedicated imaging centers for mammography screenings.
North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, widespread adoption of advanced medical technologies, and a proactive approach toward breast cancer screening and awareness. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness of breast health, expanding healthcare infrastructure, and a growing emphasis on preventive healthcare measures. For instance, Carestream Health introduced their OnDemand Mammography System with cloud-based data storage and remote diagnosis capabilities in December 2023.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Breast cancer is the most frequent cancer in women across the world, and its prevalence is increasing. This is due to a combination of variables such as aging populations, lifestyle changes, and improved screening technologies. Breast cancer identification is critical for improving treatment results and lowering death rates. Mammography is the most efficient early detection method for breast cancer, and public awareness of its relevance is expanding. For instance, Hologic, Inc. received FDA authorization for their new 3D GeniusTM Dream Edition mammography equipment with increased picture quality and quicker scan durations in December 2023.
By product, the digital mammography systems segment accounted for the highest revenue-grossing segment in the global mammography devices market in 2023 owing to the increasing adoption of advanced imaging technologies, enhanced diagnostic accuracy, and the growing trend towards digitalization in medical imaging. For instance, in September 2023, the company received CE Mark clearance for their Biograph mPower PET/CT system, which provides enhanced imaging for breast cancer staging and therapy planning. Additionally, the 3D mammography systems segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing acknowledgment of its better diagnostic capabilities, particularly in identifying breast cancer in patients with dense breast tissue.
By technology, the digital mammography segment accounted for the highest revenue-grossing segment in the global mammography devices market in 2023 owing to the increasing demand for advanced imaging technologies, a shift toward digitalization in healthcare, and the numerous advantages offered by digital mammography over traditional analog systems. For instance, in December 2023, GE Healthcare demonstrated their new Senographe Pristina 3D mammography system with AI-powered lesion detection at the RSNA annual meeting. Additionally, the 3D mammography segment is predicted to grow at the fastest CAGR during the forecast period owing to the heightened demand for improved breast cancer detection accuracy, particularly in individuals with dense breast tissue.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global mammography devices market in 2023 owing to the pivotal role hospitals play as primary healthcare centers, where a significant volume of mammography screenings and diagnostic procedures are conducted. For instance, Fujifilm Holdings Corporation collaborated with AI developer Subtle Medical in August 2023 to create AI-powered breast cancer screening capabilities for its mammography equipment. Additionally, the diagnostic imaging centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend toward outpatient services, the rising demand for specialized diagnostic procedures, and the convenience offered by dedicated imaging centers for mammography screenings.
North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, widespread adoption of advanced medical technologies, and a proactive approach toward breast cancer screening and awareness. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness of breast health, expanding healthcare infrastructure, and a growing emphasis on preventive healthcare measures. For instance, Carestream Health introduced their OnDemand Mammography System with cloud-based data storage and remote diagnosis capabilities in December 2023.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product Type, Technology, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
Segmentation: Mammography Devices Market Report 2023 - 2034
Mammography Devices Market Analysis & Forecast by Product Type 2023 - 2034 (Revenue USD Bn)
- Screen Film Mammography Systems
- Digital Mammography Systems
- Breast MRI Systems
- Breast Ultrasound Systems
- Accessories and Consumables
Mammography Devices Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- Analog Mammography
- Digital Mammography
- 3D Mammography
- Breast MRI
- Breast Ultrasound
Mammography Devices Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Breast Care Clinics
Mammography Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Mammography Devices Market: Product Type Estimates & Trend Analysis
8. Mammography Devices Market: Technology Estimates & Trend Analysis
9. Mammography Devices Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Mammography Devices Market
12. Europe Global Mammography Devices Market
13. Asia Pacific Global Mammography Devices Market
14. Latin America Global Mammography Devices Market
15. MEA Global Mammography Devices Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Becton
- Dickinson and Company
- Baxter International Inc.
- Fresenius SE & Co. KGaA
- ICU Medical Inc.
- Terumo Corporation
- Smiths Medical Inc.
- C.R. Bard Inc.
- B. Braun Melsungen AG
- Moog Inc.
- AngioDynamics Inc.
- Teleflex Incorporated
- Nipro Corporation
- Avanos Medical Inc.
- Vygon SA
- NP Medical Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | January 2024 |
Forecast Period | 2023 - 2034 |
Estimated Market Value ( USD | $ 1.54 Billion |
Forecasted Market Value ( USD | $ 4.5 Billion |
Compound Annual Growth Rate | 10.2% |
Regions Covered | Global |
No. of Companies Mentioned | 16 |